Back to News
Dec 15, 2025 12:00 PM

Cencora Strikes $5 Billion OneOncology Deal, Pauses Stock Buyback

Cencora, Inc. (NYSE:COR) on Monday agreed to acquire the majority stake it does not own in OneOncology from TPG and other shareholders for.

Cencora stock is showing positive momentum. What’s next for COR stock?

The consideration includes approximately $3.6 billion and retires its existing corporate debt of $1.3 billion, for a total consideration of approximately $5.0 billion.

OneOncology’s affiliated practices and management will retain a minority interest in OneOncology.

The transaction values the OneOncology enterprise at $7.4 billion, with an equity value of approximately $6 billion.

OneOncology Investment

Cencora had an initial investment in OneOncology, a platform to enable community medical practices to remain independent and to improve patient access ...